leisure time -WSS

leisure time

author：Wikipedia 2025-10-04 04:42:29 - browse：2914

BiTE Bridge — Illustration of a BiTE, Amgen's bispecific antibodies Amgen

In cancer immunotherapy these days, technology is advancing so fast that 2017’s buzzy new treatment may soon be passe: Only 18 months after approval of the first CAR-T, pharmaceutical companies and biotechs are already talking about next-generation cancer therapy.

Called bispecific antibodies, they’re being developed by some two dozen companies large and small, with a version cleverly branded as BiTEs already constituting 60 percent of Amgen’s oncology pipeline. The appeal: Bispecifics make the immune system kill tumor cells like first-gen immunotherapy, but, unlike the weeks it takes to laboriously manufacture CAR-Ts, they can start being infused almost as quickly as an oncologist can write a prescription.

“We’re very bullish” on BiTEs, said Dr. David Reese, head of R&D at Amgen, which has the only cancer-targeting bispecific approved for clinical use in the U.S. and 14 more in development, including for multiple myeloma, small cell lung cancer, glioblastoma, and other solid tumors. “We can generate a BiTE against any tumor antigen we want to go after.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： For Cytokinetics, FDA rejection of heart drug would help, not hinder

WSS

Maui's cultural, historic landmarks damaged in the devastating wildfires

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Friends ask where James Watson's attitudes about race came from

Male doctors called my cancer incurable. A female doctor showed it wasn't

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

hotspot

leisure time

hotspot

What does generative AI mean for health care? We asked experts

How to use technology to prevent future drug shortages

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

NIH trials fail to test meaningful long Covid therapies, experts say

Peter Hotez and the public health issue of online harassment

American woman, child freed after being kidnapped in Haiti last month

How to save PrEP access — and even expand it

Nonprofit, backed by Microsoft, to certify AI tools in health care

Cancer drug shortages should be causing more outrage

Wegovy trial has doctors encouraged over new possibilities

hotspot

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Maui's cultural, historic landmarks damaged in the devastating wildfires

Profiling embryos to choose those with higher IQs is almost a reality

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Methadone doses haven’t kept up in the age of fentanyl

Man killed during FBI raid in connection with threats against Biden, other officials

entertainment

hotspot

Wikipedia

focus